Lewin, M.R.; Carter, R.W.; Matteo, I.A.; Samuel, S.P.; Rao, S.; Fry, B.G.; Bickler, P.E.
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes. Toxins 2022, 14, 783.
https://doi.org/10.3390/toxins14110783
AMA Style
Lewin MR, Carter RW, Matteo IA, Samuel SP, Rao S, Fry BG, Bickler PE.
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes. Toxins. 2022; 14(11):783.
https://doi.org/10.3390/toxins14110783
Chicago/Turabian Style
Lewin, Matthew R., Rebecca W. Carter, Isabel A. Matteo, Stephen P. Samuel, Sunita Rao, Bryan G. Fry, and Philip E. Bickler.
2022. "Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes" Toxins 14, no. 11: 783.
https://doi.org/10.3390/toxins14110783
APA Style
Lewin, M. R., Carter, R. W., Matteo, I. A., Samuel, S. P., Rao, S., Fry, B. G., & Bickler, P. E.
(2022). Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes. Toxins, 14(11), 783.
https://doi.org/10.3390/toxins14110783